Simvastatin increases ADAMTS13 expression in podocytes

Thrombosis Research

Volumn 132, Issue 1, 2013, Pages 94-99

  Shen, Lei ^a   Lu, Guoyuan ^a   Dong, Ningzheng ^a   Ma, Zhenni ^a   Ruan, Changgeng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

ADAMTS13; IL 6; podocyte; simvastatin

Indexed keywords

INTERLEUKIN 4; INTERLEUKIN 6; SIMVASTATIN; TUMOR NECROSIS FACTOR ALPHA; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANTICOAGULATION; ARTICLE; DRUG EFFECT; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

3-HYDROXY-3-METHYLGLUTARYL COENZYME A; A DISINTEGRIN-LIKE AND METALLOPROTEASE WITH THROMBOSPONDIN TYPE 1 REPEATS 13; ADAMTS13; HMG-COA; IL-4; IL-6; INTERLEUKIN-4; INTERLEUKIN-6; PODOCYTE; SIMVASTATIN; THROMBOTIC THROMBOCYTOPENIC PURPURA; TNF-Α; TTP; TUMOR NECROSIS FACTOR-Α; VON WILLEBRAND FACTOR; VWF;

ADAM PROTEINS; ANIMALS; CELL LINE; GENE EXPRESSION REGULATION; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTERLEUKIN-4; INTERLEUKIN-6; MICE; PODOCYTES; RNA, MESSENGER; SIMVASTATIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84881313876     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.05.024     Document Type: Article

References (32)

1. G.G. Levy, W.C. Nichols, E.C. Lian, T. Foroud, J.N. McClintick, and B.M. McGee Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura Nature 413 2001 488 494 (Pubitemid 32938741)
2. J.L. Moake Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome Arch Pathol Lab Med 126 2002 1430 1433 (Pubitemid 36237296)
3. C. Loirat, A. Veyradier, J.P. Girma, A.S. Ribba, and D. Meyer Thrombotic thrombocytopenic purpura associated with von Willebrand factor-cleaving protease (ADAMTS13) deficiency in children Semin Thromb Hemost 32 2006 90 97
4. M. Manea, A. Kristoffersson, R. Schneppenheim, M.A. Saleem, P.W. Mathieson, and M. Mörgelin Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura Br J Haematol 138 2007 651 662 (Pubitemid 47206716)
5. S.J. Shankland Cell cycle regulatory proteins in glomerular disease Kidney Int 56 1999 1208 1215
6. Z.A. Massy, and C. Guijarro Statins: effects beyond cholesterol lowering Nephrol Dial Transplant 16 2001 1738 1741 (Pubitemid 32821398)
7. S. Shibata, M. Nagase, and T. Fujita Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling J Am Soc Nephrol 17 2006 754 764
8. S.Y. Jin, J. Tohyama, R.C. Bauer, N.N. Cao, D.J. Rader, and X.L. Zheng Genetic ablation of adamts13 gene dramatically accelerates the formation of early atherosclerosis in a murine model Arterioscler Thromb Vasc Biol 32 2012 1817 1823
9. L. Shen, G. Lu, N. Dong, L. Jiang, Z. Ma, and C. Ruan Von Willebrand factor, ADAMTS13 activity, TNF-α and their relationships in patients with chronic kidney disease Exp Ther Med 3 2012 530 534
10. M. Ishikawa, M. Uemura, T. Matsuyama, M. Matsumoto, H. Ishizashi, and S. Kato Potential role of enhanced cytokinemia and plasma inhibitor on the decreased activity of plasma ADAMTS13 in patients with alcoholic hepatitis: relationship to endotoxemia Alcohol Clin Exp Res 34 2010 S25 S33
11. W.J. Cao, M. Niiya, X.W. Zheng, D.Z. Shang, and X.L. Zheng Inflammatory cytokines inhibit ADAMTS13 synthesis in hepatic stellate cells and endothelial cells J Thromb Haemost 6 2008 1233 1235 (Pubitemid 351859136)
12. A. Bernardo, C. Ball, L. Nolasco, J.F. Moake, and J.F. Dong Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow Blood 104 2004 100 106 (Pubitemid 38879844)
13. P. Stenvinkel, J.J. Carrero, J. Axelsson, B. Lindholm, O. Heimbürger, and Z. Massy Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol 3 2008 505 521
14. P. Mundel, J. Reiser, A. Zúñiga Mejía Borja, H. Pavenstädt, G.R. Davidson, and W. Kriz Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines Exp Cell Res 236 1997 248 258 (Pubitemid 27452369)
15. Z. Ma, N. Dong, J. Zhang, J. Su, A. Wang, and C. Ruan Stable expression and characterization of the von Willebrand factor cleaving protease Chin J Biotechnol 26 2010 244 248 [article in Chinese]
16. T.C. Nguyen, A. Liu, L. Liu, C. Ball, H. Choi, and W.S. May Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis Haematologica 92 2007 121 124 (Pubitemid 46232666)
17. T. Ono, J. Mimuro, S. Madoiwa, K. Soejima, Y. Kashiwakura, and A. Ishiwata Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure Blood 107 2006 528 534 (Pubitemid 43076375)
18. G.Y. Lu, L. Shen, Z.Y. Wang, X.F. Guo, X. Bai, and J. Su Significance of plasma von Willebrand factor level and von Willebrand factor-cleaving protease activity in patients with chronic renal diseases Chin Med J 121 2008 133 136 (Pubitemid 351247886)
19. A.O. Spiel, J.C. Gilbert, and B. Jilma von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes Circulation 117 2008 1449 1459 (Pubitemid 351501497)
20. A. Upadhyay, M.G. Larson, C.Y. Guo, R.S. Vasan, I. Lipinska, and C.J. O'Donnell Inflammation, kidney function and albuminuria in the Framingham Offspring cohort Nephrol Dial Transplant 26 2011 920 926
21. L. Fried, C. Solomon, M. Shlipak, S. Seliger, C. Stehman-Breen, and A.J. Bleyer Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals J Am Soc Nephrol 15 2004 3184 3191 (Pubitemid 39578851)
22. R. Pecoits-Filho, O. Heimbürger, P. Bárány, M. Suliman, I. Fehrman-Ekholm, and B. Lindholm Associations between circulating inflammatory markers and residual renal function in CRF patients Am J Kidney Dis 41 2003 1212 1218 (Pubitemid 36637976)
23. M. Niiya, M. Uemura, X.W. Zheng, E.S. Pollak, M. Dockal, and F. Scheiflinger Increased ADAMTS-13 proteolytic activity in rat hepatic stellate cells upon activation in vitro and in vivo J Thromb Haemost 4 2006 1063 1070
24. M. Uemura, K. Tatsumi, M. Matsumoto, M. Fujimoto, T. Matsuyama, and M. Ishikawa Localization of ADAMTS13 to the stellate cells of human liver Blood 106 2005 922 924 (Pubitemid 41076434)
25. D. Shang, X.W. Zheng, M. Niiya, and X.L. Zheng Apical sorting of ADAMTS13 in vascular endothelial cells and Madin-Darby canine kidney cells depends on the CUB domains and their association with lipid rafts Blood 108 2006 2207 2215 (Pubitemid 44497501)
26. Z.H. Chen, W.S. Qin, C.H. Zeng, C.X. Zheng, Y.M. Hong, and Y.Z. Lu Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro Kidney Int 77 2010 974 988
27. C.X. Zheng, Z.H. Chen, C.H. Zeng, W.S. Qin, L.S. Li, and Z.H. Liu Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro Kidney Int 74 2008 596 612
28. J. Heusinger-Ribeiro, B. Fischer, and M. Goppelt-Struebe Differential effects of simvastatin on mesangial cells Kidney Int 66 2004 187 195 (Pubitemid 38870094)
29. L.M. Biasucci, G. Biasillo, and A. Stefanelli Inflammatory markers, cholesterol and statins: pathophysiological role and clinical importance Clin Chem Lab Med 48 2010 1685 1691
30. C. Gandhi, M.M. Khan, S.R. Lentz, and A.K. Chauhan ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice Blood 119 2012 2385 2391
31. S. Blanco, M. Vaquero, C. Gomez-Guerrero, D. Lopez, J. Egido, and R. Romero Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension Am J Hypertens 18 2005 557 565
32. A. Whaley-Connell, V.G. Demarco, G. Lastra, C. Manrique, R. Nistala, and S.A. Cooper Insulin resistance, oxidative stress, and podocyte injury: role of rosuvastatin modulation of filtration barrier injury Am J Nephrol 28 2007 67 75 (Pubitemid 350126495)